• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN SURGICAL TRI-STAPLE 2.0; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN SURGICAL TRI-STAPLE 2.0; STAPLE, IMPLANTABLE Back to Search Results
Model Number SIG30CTAVM
Medical Device Problem Code Failure to Form Staple (2579)
Health Effect - Clinical Code Tissue Breakdown (2681)
Date of Event 01/09/2026
Type of Reportable Event Malfunction
Event or Problem Description
According to the reporter, during the segmentectomy procedure typical of the culmen or upper lobe of the left upper lobe using the single-port technique with a wound protection system from another manufacturer, the surgeon detected an anomalous configuration of the staples of the three vascular cartridges.Two on the arterial branch and one on the venous branch.It was noted that a powered handle was used then a manual stapler was used to resolve the issue.
 
Additional Manufacturer Narrative
D10.Concomitant products: sig30ctavm, tri 2.0 sig30ctavm 30 ct vsclr med 12mm (lot# n4g1873y).Sig30ctavm, tri 2.0 sig30ctavm 30 ct vsclr med 12mm (lot# n4g1873y).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Correction: h3 (evaluation summary) h3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was not returned, but a photo was available for evaluation.Visual inspection noted the results of staple lines in the patient's tissue.Several of the staples were malformed.It was reported that the surgeon detected an anomalous configuration of the staples.The reported issue was confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.A secondary review of the device history records found no potentially contributing factors.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Additional information: g3, h3, h6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.Visual inspection noted the results of staple lines in the patient's tissue.Several of the staples were malformed.It was reported that the surgeon detected an anomalous configuration of the staples.The reported issue was confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.A secondary review of the device history records found no potentially contributing factors.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRI-STAPLE 2.0
Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
COVIDIEN SURGICAL
60 middletown ave
north haven CT 06473
Manufacturer (Section G)
COVIDIEN SURGICAL
60 middletown ave
north haven CT 06473
Manufacturer Contact
mike bocchino
8200 coral sea st ne
mounds view, MN 55112-4391
8006464633
MDR Report Key24083042
Report Number1219930-2026-00287
Device Sequence Number20281029
Product Code GDW
UDI-Device Identifier10884521543744
UDI-Public(01)10884521543744(17)290630(10)N4G1873Y(20)03
Combination Product (Y/N)N
Initial Reporter CountryIT
PMA/510(K) Number
K160176
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/08/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberSIG30CTAVM
Device Catalogue NumberSIG30CTAVM
Device Lot NumberN4G1873Y
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/09/2026
Supplement Date Received by Manufacturer03/27/2026
04/08/2026
Initial Report FDA Received Date01/15/2026
Supplement Report FDA Received Date04/08/2026
04/08/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/17/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11
Patient Age73 YR
Patient SexFemale
-
-